Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jennifer Lynn Guerriero, Ph.D.

Concepts (248)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tumor Microenvironment18202438781.120 Why?
Macrophages8202457671.060 Why?
Receptors, Progesterone3202111290.680 Why?
Neovascularization, Pathologic2202126450.650 Why?
Mammary Neoplasms, Experimental120215070.620 Why?
Neoplasms, Experimental3202012290.590 Why?
Breast Neoplasms102024210190.590 Why?
Histone Deacetylase Inhibitors320217740.520 Why?
Antineoplastic Agents, Alkylating220116170.520 Why?
Receptors, Estrogen3202422090.480 Why?
Lymphocytes, Tumor-Infiltrating7202110920.470 Why?
Receptor, erbB-23202325570.460 Why?
Immunotherapy7202446520.400 Why?
Immune Tolerance1202123020.390 Why?
Cell Line, Tumor152024169900.370 Why?
Drug Resistance, Neoplasm7202153050.350 Why?
HMGB1 Protein120111370.330 Why?
Neoplasms72024221730.310 Why?
Glioblastoma1202334830.300 Why?
Apoptosis8202194900.290 Why?
Myeloid Cells220238230.290 Why?
Lymphocyte Activation1201854850.290 Why?
Lung Neoplasms22024133810.260 Why?
Immunity, Innate3201930660.260 Why?
bcl-X Protein220194100.260 Why?
T-Lymphocytes22021101940.240 Why?
Cyclophosphamide1200822200.210 Why?
Antineoplastic Agents42019136420.200 Why?
Quality Control120248320.190 Why?
Phagocytosis2201815280.190 Why?
Transplantation, Isogeneic120212480.190 Why?
Antineoplastic Combined Chemotherapy Protocols62023117420.180 Why?
Antibodies, Bispecific120231960.180 Why?
Ketones120211840.180 Why?
Furans120212020.180 Why?
Professional-Family Relations220214950.170 Why?
Allergy and Immunology120211760.170 Why?
DNA-Directed DNA Polymerase120234890.170 Why?
CD8-Positive T-Lymphocytes4202345800.170 Why?
Animals2020241684750.170 Why?
Death Domain Receptor Signaling Adaptor Proteins12019330.160 Why?
Mammary Glands, Animal120202730.160 Why?
Mice142024815390.160 Why?
Neoplasm Transplantation2202120160.160 Why?
Caregivers2202122380.150 Why?
Health Communication120212130.150 Why?
Pyrimidinones120203850.150 Why?
Monoclonal Gammopathy of Undetermined Significance120201790.150 Why?
Macrophage Activation220205530.150 Why?
Humans4520247615960.150 Why?
Single-Cell Analysis3202424510.150 Why?
Seizures2202129570.150 Why?
Receptors, Immunologic1202414100.140 Why?
Cisplatin2202016520.140 Why?
Oxadiazoles12017940.140 Why?
Necrosis3201116110.140 Why?
BRCA1 Protein2202011580.140 Why?
Urothelium120192690.140 Why?
Parents2202135630.140 Why?
Xenograft Model Antitumor Assays5202036050.130 Why?
Drug Synergism2201717570.130 Why?
Apoptosis Regulatory Proteins2201911360.130 Why?
Infant, Newborn, Diseases120215890.130 Why?
Artifacts1202419110.130 Why?
Neoplasm Metastasis3202149150.130 Why?
Paclitaxel5202317320.120 Why?
Stromal Cells1202013300.120 Why?
Immunologic Factors2202115900.120 Why?
Estrogen Receptor alpha120195830.120 Why?
Mice, Nude3201136140.120 Why?
Neoadjuvant Therapy3202328280.120 Why?
Adaptive Immunity120197260.120 Why?
Hydroxamic Acids120174810.110 Why?
Gene Expression Profiling3202194200.110 Why?
Female2320243927050.110 Why?
Membrane Glycoproteins1202437010.110 Why?
Antigens, CD1202340010.100 Why?
Drug Administration Schedule1202148530.100 Why?
Ovarian Neoplasms2201948780.100 Why?
Carcinoma, Pancreatic Ductal1202317280.100 Why?
Multiple Myeloma3202051460.100 Why?
Neoplasms, Germ Cell and Embryonal120164910.100 Why?
Colorectal Neoplasms2202269380.090 Why?
Benzamides1201713710.090 Why?
Tumor Burden1201718920.090 Why?
Cell Proliferation42021104510.090 Why?
Software1202444340.090 Why?
Class Ia Phosphatidylinositol 3-Kinase12010770.090 Why?
Cell Transformation, Neoplastic1202028270.090 Why?
Pyrazoles1202020090.090 Why?
Cell Differentiation22018115300.090 Why?
Molecular Targeted Therapy2201928110.090 Why?
Cell Line, Transformed120118660.080 Why?
Serpins120112470.080 Why?
Adaptation, Psychological1202026290.080 Why?
Adenovirus E1A Proteins12008740.080 Why?
Evidence-Based Medicine1202136880.080 Why?
Mice, Transgenic1202195420.080 Why?
bcl-2 Homologous Antagonist-Killer Protein12008710.080 Why?
Epithelial Cells1202036770.080 Why?
Proto-Oncogene Proteins c-bcl-21201514060.080 Why?
Peptides2202443580.080 Why?
Colonic Neoplasms1202025390.080 Why?
Fibroblasts2201641420.080 Why?
Genome, Human2202144250.070 Why?
Image Processing, Computer-Assisted1202490010.070 Why?
bcl-2-Associated X Protein120082820.070 Why?
Signal Transduction42024234470.070 Why?
Cytokines2202173960.070 Why?
Random Allocation1201123950.070 Why?
Urinary Bladder Neoplasms1201922230.070 Why?
Genes, ras120086540.060 Why?
Biomedical Research1202134290.060 Why?
Carcinoma, Renal Cell1202131650.060 Why?
DNA-Binding Proteins2202196100.060 Why?
Pancreatic Neoplasms1202353680.060 Why?
Lung12024100020.060 Why?
Clinical Trials as Topic1202180020.060 Why?
Pyrimidines1201730280.060 Why?
Taxoids120086680.060 Why?
HEK293 Cells2201142810.060 Why?
Stress, Psychological1202044810.060 Why?
Kidney Neoplasms1202142510.060 Why?
Genomics4202158210.050 Why?
Physicians1202145910.050 Why?
Gene Expression Regulation, Neoplastic2201985540.050 Why?
DNA, Neoplasm1200817450.050 Why?
Cells, Cultured32020189660.050 Why?
Antigens, Neoplasm1201119930.050 Why?
Gene Expression Regulation12020119040.050 Why?
Autophagy1201013270.050 Why?
Membrane Proteins1201978590.050 Why?
Aging1202087100.050 Why?
Treatment Outcome42021646850.050 Why?
Antibodies, Monoclonal1201891770.050 Why?
Qualitative Research2202130250.040 Why?
Risk Assessment12021239960.040 Why?
Disease Models, Animal22017182550.040 Why?
Time Factors12021399690.040 Why?
Nuclear Family120203110.040 Why?
Nucleotides, Cyclic12019840.040 Why?
DNA Damage1200824490.040 Why?
Atlases as Topic120202480.040 Why?
Carcinoma, Non-Small-Cell Lung1201753140.040 Why?
Prospective Studies52023544230.040 Why?
Genetic Heterogeneity120217320.040 Why?
Prognosis42021296290.040 Why?
Cell Communication1202416570.040 Why?
Object Attachment120203260.040 Why?
Disease Progression42019135100.040 Why?
Risk Factors22022742130.040 Why?
Antibody-Dependent Cell Cytotoxicity120183030.030 Why?
Microsatellite Instability120207160.030 Why?
Burns1200818820.030 Why?
Genes, Tumor Suppressor1202010620.030 Why?
Carboplatin120197940.030 Why?
Antigen Presentation1202112510.030 Why?
Octamer Transcription Factor-3120162230.030 Why?
Male1020213608460.030 Why?
Uncertainty120207540.030 Why?
Cytochromes c120151730.030 Why?
Estrogens1202115220.030 Why?
Loss of Heterozygosity120166620.030 Why?
BRCA2 Protein120198050.030 Why?
Parenting120207010.030 Why?
Health Care Surveys1202124260.030 Why?
Interleukin-101201911750.030 Why?
Teratoma120164040.030 Why?
Middle Aged720232209210.030 Why?
Phenotype22021165920.030 Why?
Aged620231693100.030 Why?
Lymphocytes1202026120.030 Why?
Mitochondria2201636240.030 Why?
Transcription Factors22023121300.030 Why?
Histone Deacetylases120177200.030 Why?
Biological Assay120156260.030 Why?
Mutation32024300530.020 Why?
Chemotherapy, Adjuvant1202035140.020 Why?
Sequence Analysis, RNA1202020210.020 Why?
Leadership1202113850.020 Why?
Plasma Cells120155990.020 Why?
Protein-Tyrosine Kinases1202024250.020 Why?
Fear1202014770.020 Why?
Class III Phosphatidylinositol 3-Kinases12010170.020 Why?
Infant, Newborn22021262020.020 Why?
Organ Specificity1201519680.020 Why?
Testicular Neoplasms120167990.020 Why?
Phosphatidylinositol Phosphates120102010.020 Why?
Aniline Compounds1201510690.020 Why?
Antibodies, Neoplasm120112810.020 Why?
Dendritic Cells1202027470.020 Why?
Phagosomes120101990.020 Why?
Tissue Array Analysis120115500.020 Why?
Cell Cycle Proteins1202034490.020 Why?
Phylogeny1201628110.020 Why?
Adaptor Proteins, Vesicular Transport120103050.020 Why?
Patient Care Team1202025210.020 Why?
Killer Cells, Natural1201822010.020 Why?
Nuclear Proteins1202357990.020 Why?
Proto-Oncogene Proteins p21(ras)1201617450.020 Why?
High-Throughput Nucleotide Sequencing1202036390.020 Why?
Evolution, Molecular1201618860.020 Why?
Biopolymers120081840.020 Why?
Combined Modality Therapy1201985270.020 Why?
Survival Rate12021127230.020 Why?
CD4-Positive T-Lymphocytes1201943690.020 Why?
Survival Analysis12019100900.020 Why?
Early Detection of Cancer1202132010.020 Why?
Tumor Suppressor Protein p531201629170.020 Why?
Adult420212212100.020 Why?
Proportional Hazards Models12020124630.020 Why?
Drug Screening Assays, Antitumor120087180.020 Why?
Sulfonamides1201519790.020 Why?
Immunohistochemistry12019110760.020 Why?
Anxiety1202045730.020 Why?
Immunoenzyme Techniques1200817040.020 Why?
Smoking1202290530.020 Why?
Embryo, Mammalian1201016740.010 Why?
Tubulin120086930.010 Why?
Incidence12022213550.010 Why?
Drug Design1200810480.010 Why?
Point Mutation1200815950.010 Why?
Recurrence1201584660.010 Why?
Structure-Activity Relationship1200830760.010 Why?
Mice, Inbred C57BL12020221740.010 Why?
Recombinant Fusion Proteins1201037330.010 Why?
Proto-Oncogene Proteins c-akt1201024570.010 Why?
Disease-Free Survival1201168150.010 Why?
Follow-Up Studies12022391060.010 Why?
Enzyme Inhibitors1201037130.010 Why?
Transplantation, Heterologous1200823860.010 Why?
Ischemia1200818840.010 Why?
Infant12021361930.010 Why?
Quality of Life12020133670.010 Why?
Child, Preschool12021422320.010 Why?
Heart1201044040.010 Why?
Rats, Sprague-Dawley1200881810.010 Why?
Biopsy1200867660.010 Why?
Neoplasm Staging12011111200.010 Why?
Mice, Knockout12010144170.010 Why?
Liver1201075280.010 Why?
Pilot Projects1200886330.010 Why?
Skin1200844840.010 Why?
Young Adult12020592600.010 Why?
Reproducibility of Results12011201000.010 Why?
United States12020723400.010 Why?
Rats12008237410.010 Why?
Aged, 80 and over12015589840.010 Why?
Guerriero's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (248)
Explore
_
Co-Authors (108)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.